Effects of Hydrogen Sulfide-releasing l-DOPA Derivatives on Glial Activation: POTENTIAL FOR TREATING PARKINSON DISEASE

The main lesion in Parkinson disease (PD) is loss of substantia nigra dopaminergic neurons. Levodopa (l-DOPA) is the most widely used therapy, but it does not arrest disease progression. Some possible contributing factors to the continuing neuronal loss are oxidative stress, including oxidation of l...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lee, Moonhee, Tazzari, Valerio, Giustarini, Daniela, Rossi, Ranieri, Sparatore, Anna, Del Soldato, Piero, McGeer, Edith, McGeer, Patrick L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Biochemistry and Molecular Biology 2010
Soggetti:
Molecular Bases of Disease
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2878495/
https://ncbi.nlm.nih.gov/pubmed/20368333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M110.115261
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi